Release test results
99.744%HPLC purity · meets ≥ 99.5% spec
Mass-spec identityConfirmed · 20.14 mg
Related impurities (total)0.256%
Endotoxin<1.0 EU/mg
HPLC retention time7.56 min
MethodHPLC + LC-MS
ResultPass · meets spec
Lot record
CompoundMOTS-C
Presentation20 MG
Lot numberRGX-26-RGNX-677
COA numberNS-2026-05122
Test date06 Sep 2026
Release date09 Sep 2026
Independent labNordicstar Labs
StatusSuperseded
MOTS-C — lot history
| Lot | Presentation | Tested | HPLC purity | Status |
|---|---|---|---|---|
| RGX-26-RGNX-1023 | 20 MG | Sep 8, 2026 | 99.678% | Current |
| RGX-26-RGNX-676 | 30 MG | Sep 8, 2026 | 99.737% | Superseded |
| RGX-26-RGNX-778 | 10 MG | Sep 7, 2026 | 99.592% | Superseded |
| RGX-26-RGNX-777 | 20 MG | Sep 7, 2026 | 99.630% | Superseded |
| RGX-26-RGNX-1022 | 10 MG | Sep 6, 2026 | 99.640% | Current |
| RGX-26-RGNX-677 this lot | 20 MG | Sep 6, 2026 | 99.744% | Superseded |
| RGX-26-RGNX-775 | 40 MG | Sep 6, 2026 | 99.699% | Superseded |
| RGX-26-RGNX-1025 | 40 MG | Sep 5, 2026 | 99.754% | Current |
| RGX-26-RGNX-675 | 40 MG | Sep 5, 2026 | 99.592% | Superseded |
| RGX-26-RGNX-776 | 30 MG | Sep 4, 2026 | 99.706% | Superseded |
| RGX-26-RGNX-1024 | 30 MG | Sep 3, 2026 | 99.716% | Current |
| RGX-26-RGNX-678 | 10 MG | Sep 2, 2026 | 99.668% | Superseded |
!
Research use only
This lot record documents a research compound sold for laboratory use only — not for human or animal consumption. Results are as tested by Nordicstar Labs; retained samples are archived for five years. Research Use Agreement →